Reply to ‘H-STS, L-STS and KRJ-I are not authentic GEPNET cell lines’

समान संसाधन

• MEDICAL MANAGEMENT OF GEPNETS
  द्वारा: Chandrasekharan, Chandrikha
  प्रकाशित: (2020)
• Emerging Therapeutic Implications of STK11 Mutation: Case Series
  द्वारा: Laderian, Bahar, और अन्य
  प्रकाशित: (2020)
• In Reply
  द्वारा: Yao, James, और अन्य
  प्रकाशित: (2013)
• Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned
  द्वारा: Yao, James C., और अन्य
  प्रकाशित: (2013)
• The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines
  द्वारा: Hofving, Tobias, और अन्य
  प्रकाशित: (2018)